Responses
Drug information and pharmacotherapy
DI-099 Similarity assessment of reference remicade (infliximab) and its marketed biosimilar inflectra by means of aggregates profile over time and freeze/thaw stress
Compose a Response to This Article
Other responses
No responses have been published for this article.